Clinical Trial Update: Iron Depletion Therapy for Type 2 DM and NAFLD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates completion of a study evaluating iron depletion therapy for individuals with non-alcoholic fatty liver disease and typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Non-Alcoholic Fatty Liver Disease, Diabetes Mellitus | Phase 2 | Status: COMPLETED